@article{8d29a856eec44c9faf6bd9cad5b81220,
title = "The risk of drug-eluting stent thrombosis with noncardiac surgery",
abstract = "Patients in whom any kind of stent, particularly a drug-eluting stent (DES), was recently implanted are at risk for stent thrombosis when they undergo noncardiac surgery, even months or years after their implantation. The risk of DES thrombosis is likely decreased by delaying noncardiac surgery for as long as possible and continuing dual or at least single antiplatelet therapy in the perioperative period. Preoperative identification and close monitoring of patients with DES may allow prevention and prompt detection and treatment of this catastrophic complication.",
author = "Brilakis, {Emmanouil S.} and Subhash Banerjee and Berger, {Peter B.}",
note = "Funding Information: We gratefully acknowledge the contribution of Michele Roesle, RN in this manuscript preparation. Emmanouil S. Brilakis receives support from the Clark R. Gregg Fund, Harris Methodist Health Foundation 6100 Western Place, Suite 1001, Fort Worth, TX 76107, USA, and from a Veterans Affairs VISN 17 startup award, Waco, Texas, USA. Peter B. Berger receives honoraria for speaking at Continuing Medical Education (CME)-approved scientific symposia supported by Bristol-Myers Squibb, Sanofi-Aventis, and Lilly/Daiichi-Sankyo, honoraria from Biogen and Scher-ing-Plough, and served as a consultant to Boston Scientific.",
year = "2007",
month = sep,
doi = "10.1007/BF02938368",
language = "English (US)",
volume = "9",
pages = "406--411",
journal = "Current Cardiology Reports",
issn = "1523-3782",
publisher = "Current Medicine Group",
number = "5",
}